What is NDC 65862-928?

65862-928 is the product NDC for Sumatriptan and Naproxen Sodium, Sumatriptan succinate 85 mg/1; Naproxen sodium 500 mg/1 tablet, film coated, listed with the FDA by Aurobindo Pharma Limited. It has 1 package NDC, shown above in 10- and 11-digit form.

What is the active ingredient?

Sumatriptan succinate, Naproxen sodium.

Aurobindo Pharma Limited, NDC labeler code 65862. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Sumatriptan and Naproxen Sodium?

2 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Sumatriptan and Naproxen Sodium NDC 65862-928

NDC codes

FDA NDC Directory

Product NDC (as listed)65862-928Labeler and product segments. Claims need a package NDC.

Product NDC at billing width65862-0928Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
65862-928-36	65862092836	9 TABLET, FILM COATED in 1 BOTTLE (65862-928-36)Marketed from Feb 15, 2018

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Sumatriptan and Naproxen Sodium
Generic name (nonproprietary): sumatriptan and naproxen sodium
Active ingredients: Sumatriptan succinate — 85 mg/1Naproxen sodium — 500 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Aurobindo Pharma LimitedNDC labeler code 65862
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 207457
Marketing start: Feb 15, 2018
Listing expires: Dec 31, 2026
Other FDA classes: Non-Steroidal (Chemical structure)Cyclooxygenase Inhibitors (Mechanism)Serotonin 1b Receptor Agonists (Mechanism)Serotonin 1d Receptor Agonists (Mechanism)
Identifiers: Product ID 65862-928_b0441826-19e2-4113-89b7-727a2b882a09SPL ID b0441826-19e2-4113-89b7-727a2b882a09SPL set ID f5203c66-0a40-4263-a237-b71e930e4697RxCUI 849450UNII J8BDZ68989, 9TN87S3A3C
Pharmacologic class: Nonsteroidal Anti-inflammatory Drug; Serotonin-1b and Serotonin-1d Receptor Agonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N465862092836 followed by a unit qualifier and the quantity

Package 65862-0928-36. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 5, 2024. This label includes a boxed warning.

Indications (excerpt from the label)

Sumatriptan and naproxen sodium tablets are indicated for the acute treatment of migraine with or without aura in adults and pediatric patients 12 years of age and older. Limitations of Use: Use only if a clear diagnosis of migraine headache has been established. If a patient has no response to the first migraine attack treated with sumatriptan and naproxen sodium tablets, reconsider the diagnosis of migraine before sumatriptan and naproxen sodium tablets are administered to treat any subsequent attacks. Sumatriptan and naproxen sodium tablets are not indicated for the prevention of migraine attacks. Safety and effectiveness of sumatriptan and naproxen sodium tablets have not been establishe…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 65862-928

What is NDC 65862-928?: 65862-928 is the product NDC for Sumatriptan and Naproxen Sodium, Sumatriptan succinate 85 mg/1; Naproxen sodium 500 mg/1 tablet, film coated, listed with the FDA by Aurobindo Pharma Limited. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Sumatriptan and Naproxen Sodium.
What is the active ingredient?: Sumatriptan succinate, Naproxen sodium.
Who is the labeler?: Aurobindo Pharma Limited, NDC labeler code 65862. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Sumatriptan and Naproxen Sodium?: 2 other product NDCs are listed under this name. See all Sumatriptan and Naproxen Sodium NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Sumatriptan and Naproxen Sodium NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Sumatriptan and Naproxen Sodium	Sumatriptan succinate 85 mg/1; Naproxen sodium 500 mg/1	Tablet, Film coatedOral	NorthStar RxLLC	16714-891	16714-0891-01
Sumatriptan and Naproxen Sodium	Sumatriptan succinate 85 mg/1; Naproxen sodium 500 mg/1	Tablet, Film coatedOral	Sun Pharmaceutical Industries, Inc.	47335-410	47335-0410-2247335-0410-8347335-0410-88